New small molecules are created by binding a drug to a target protein. But not all proteins have easily identifiable binding pockets. Belharra’s proprietary chemoproteomics platform is able to illuminate binding pockets on elusive, high-value drug targets across the proteome.
News
TIMELINE SINGLE TEMPLATE